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ABSTRACT
Background: Recently there are various non-skeletal diseases associated
with vitamin D deficiency such as type 2 diabetes mellitus (T2DM). The
main target of this study is to investigate whether there is any relationship
between serum Vitamin D levels and the glycemic control in type 2 diabetic
patients. Methods: The study was carried out in Najran University
Hospital, this study involved 275 type 2 diabetic patients and 136 healthy
control. Fasting blood glucose (FBG), HbA1c and 25(OH) vitamin D were
analyzed. Results: The results showed (8%) of diabetic patients presented
with severe Vitamin D deficiency, (27. 6%) presented with moderate
deficiency, (19.6%) presented with insufficiency and (44.7%) presented
with sufficient levels. HbA1c % and FBG were negatively correlated with
Vitamin D levels. The mean levels of vitamin D showed a highly
significant difference p > 0.001 between diabetic patients (27.84 ± 14.847
ng/ml) and healthy control subjects (53.99 ± 11.401 ng/ml), Also results
showed a highly significant difference p > 0.001 in vitamin D level
between controlled and uncontrolled diabetic patients the level of vitamin D
was (46.4 ± 17.5; 28.2 ± 14.9) respectively. Conclusion: The findings
suggested that there was a high incidence of vitamin D deficiency in type 2
diabetic patients and there was an inverse relationship between Vitamin D
and FBG and HbA1c.
Keywords: Type II diabetes; 25 hydroxycholecalciferol; HbA1c

INTRODUCTION
everal emerging studies have highlighted
the crucial association between vitamin D
deficiency and metabolic disorders like,
diabetes mellitus. The main culprit behind the
development of diabetes and vitamin D
deficiency will be brought into attention in our
study.
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The relationship between vitamin D and
diabetes has received substantial interest.
Recent theoretical developments have revealed
that there are various diseases associated with
vitamin D deficiency that are non-skeletal in
origin .These diseases include type 2 diabetes
mellitus (T2DM) that has been reported with
vitamin D deficiency [1]. Several evidence
suggests that vitamin D (25Hydroxy (OH) D]
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may play role in development of T2DM and
insulin resistance [1]. We aim is to investigate
the association between serum 25(OH) D levels
with insulin resistance.
We will review the main approaches to the
actions of vitamin D that correlate with vitamin
D deficiency and development of diabetes
mellitus. The foremost mechanisms of actions
of vitamin D are highlighted here and they
include the following.
Vitamin D, as a critical and essential
micronutrient for the human health has
achieved an ample and global attention , It
exhibits a variety non-skeletal effects that
includes but not limited to its potential in
secretion and action of insulin .It increases
insulin sensitivity that might be mediated via
binding of 1,25(OH)2D to vitamin D receptor
(VDR). In addition, it causes induction of
insulin receptors (IRs) expression on target
tissues as well as activation of peroxisome
proliferation activated receptor δ (PPAR-δ).
Moreover, it stimulates IRs in target insulinresponsive tissues [2].
In humans as well as animals it has been shown
that type 2 diabetes mellitus, decreased insulin
secretion and increased insulin resistance are all
associated with vitamin D deficiency [3].
Moreover, as shown per studies a pivotal
functional role in the glucose tolerance has
been exhibited by vitamin D effects on insulin
secretion and insulin sensitivity [4]. Mechanism
of action of vitamin D is via the stimulation of
the synthesis of insulin, the pancreatic β cells
protection, reduction in the insulin resistance in
muscles and the regulation of the adipogenesis
mechanism during adipocyte differentiation.
Consequently vitamin D is a crucial factor in
the development of T2DM [5]. Recently, the
role of Vitamin D has highlighted a widespread
interest in the pathogenesis and clinical
presentations of diabetes [6]. Been a major
calcium homeostasis regulator vitamin D can
both directly and indirectly via the activation of
calcium-dependent endopeptidases improve
insulin exocytosis [7]. Vitamin D as an
efficient antioxidant plays a role in the
prevention of T2DM and it is complications as
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well [8]. The vitamin D steroid hormone form
plays a role in the promotion of suppressor cell
activity and the inhibition of cytotoxic T
lymphocytes (Tc), macrophages, delayed
hypersensitivity type, and the generation of
natural killer (NK) cells. It exerts its action in
various organs and biological systems via
mediating several non- calcemic functions
through the regulation of cellular proliferation,
differentiation and replication, and as a
mediator of autoimmune reactions as well [8].
Deficiency of 25(OH) cholecalciferol has been
implicated in the pathogenesis of diabetes
although exact pathophysiological pathways
remain unclear [9].
This study constitutes a relatively new area
which has emerged to detect whether there is
any correlation between vitamin D and T2DM
or not.
METHODS
The study included 275 diabetic patients (166
Male 60.4% and 109 Female 39.6%) attending
the outpatient clinic of Najran University
Hospital and 136 healthy controls (76 Male
55.9% and 60 Female 44.1%) from Najran area
between August 2016 and October 2017. FBG
was measured by COBAS INTEGRA 400 and a
Roche diagnostics commercial kits, HbA1c was
estimated using the Nycocard HbA1c method.
While 25(OH) vitamin D was measured using
the ELISA technique by kits manufactured by
Abcam Company. Weight and height were
measured using a standardized scale for weight
and height and then BMI was calculated as
weight in kilograms divided by the square of
height in meters.
We classified the participant according to
25(OH) vitamin D deficiency into four main
categories: severe deficiency, <10 ng/ml (25
nmol/l); moderate deficiency, 10-19.9 ng/ml
(25-49.9 nmol/l); insufficiency, 20-29.9 ng/ml
(50-74.9 nmol/l); sufficiency, ≥30 ng/ml (75
nmol/l) [10 - 11].
All patients were assured that all their obtained
information will be handled in a confidential
atmosphere and it will not affect their life after
taking verbal and written consent. Ethical
clearance and protocol approval was obtained
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control subjects, the levels were ( 9.7 ± 2.3 % )
from the research and ethics committee of
and (5.5 ± 0.7%) respectively.
Najran University, KSA. All procedures
25(OH) vitamin D showed a highly significant
followed were following the ethical standards
difference between studied groups p > 0.001.
of the responsible committee on human
The higher levels were shown in the healthy
experimentation (institutional and national) and
control group (53.99 ± 11.401 ng/ml) followed
with the Helsinki Declaration of 1975, as
by diabetic patients with mean (27.84 ± 14.847
revised in Brazil 2013.
ng/ml) table 2.
Statistical analysis: Results of this study were
HbA1c % in table 3 shows a highly significant
statistically analyzed using (SPSS) program.
difference p >0.001 among studied groups, the
Significant differences between groups were
higher percentage was shown in insufficiency
assessed by one-way ANOVA and t-test.
group (10.1 ± 2.0 %), and severe deficiency
Correlation matrix was done and the r values
(10.1 ± 2.8 %), followed by sufficiency group
were obtained with the level of significance.
(9.8 ± 2.3 %), moderate deficiency (9.2 ± 2.3
RESULTS
%), and finally control group was the lowest
This study involved 275 diabetic patients (166
percentage (5.5 ± 0.7 %).
Male 60.4% and 109 Female 39.6%) and 136
Figure 1 shows that there is a highly significant
Healthy individuals as a control group (76 Male
deferent in 25(OH) vitamin D level between
55.9% and 60 Female 44.1%).
controlled and uncontrolled diabetic patients
The study results showed 55.3% of diabetic
the highest levels was shown in patients with
patients suffering from vitamin D deficiency.
HbA1c less than 7%, the level of 25(OH)
Chi Square test was highly significant (p <
vitamin D was (46.4 ± 17.5; 28.2 ± 14.9
0.001) and the results showed that 22 (8%) of
respectively with significant level less than
diabetic patients had severe 25(OH) vitamin D
0.001.
deficiency (<10 ng/ml), whereas, 76 (27. 6%)
25(OH) vitamin D levels was shows highly
of diabetic patients with moderate deficiency
significant difference p >0.001 in studied
(10 to 19.9 ng/ml), 54 (19.6%) of diabetic
groups, the highest concentration shown in
patients presented with insufficiency (20 to
control group, followed by sufficiency group,
29.9 ng/ml) and finally 123 (44.7%) presented
followed by insufficiency group, followed by
with sufficient levels of 25(OH) vitamin D (≥30
moderate deficiency and finally severe
ng/ml) (Table 1).
deficiency, and the concentration as follow
FBG concentration in Table 2 shows a highly
(54.0 ± 11.4 ng/ml), (41.9± 9.3 ng/ml), (23.1 ±
significant different p > 0.001 between diabetic
2.7 ng/ml), (14.6 ± 2.4 ng/ml) and (6.6 ± 1.4
patients and healthy control subjects, the higher
ng/ml) respectively (Figure 2).
concentration was for diabetic patients with
On the other hand 25(OH) vitamin D was nonmean concentration (203.6 ± 81.5 mg/dl) and
significantly correlated to HbA1c (r = 0.044; p
(79.0 ± 12.6 mg/dl) for healthy control.
Results presented in Table 2 showed a highly
= 0.470) (figure 3), and it was non-significantly
negatively correlated to FBG (r = -0.032; p =
significant different p > 0.001 in HbA1c
0.603) (Figure 3 and 4).
percent between diabetic patients and healthy
Table 1. The distribution of study population among studied groups.
Study groups
Severe deficiency
Moderate deficiency
Insufficiency
Sufficiency
Total
Amar B., et al..
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Diabetic Patients
22 (8%)
76 (27.6 %)
54 (19.6 %)
123 (44.7 %)
275 (100 %)

Healthy Control
0
0
0
136 (100%)
136 (100%)
134 | P a g e
3

Zagazig University Medical Journal, Vol. 27 [2021], Iss. 1, Art. 36

January. 2021 Volume 27 Issue 1

10.21608/zumj.2020.26422.1782

Table 2. Mean of some parameters in diabetic patients and healthy control subjects.
parameters
Mean ± SD
sig
Diabetic patients
Healthy Control
BMI
34.0 ± 6.7
26.1 ± 2.7
0.000
Systolic BP
125.9 ± 15.3
119.3 ± 4.8
0.000
Diastolic BP
72.74 ± 15.0
81.0 ± 4.2
0.000
FBG mg/dl
203.6 ± 81.5
79.0 ± 12.6
0.000
HbA1c%
9.7 ± 2.3
5.5 ± 0.7
0.000
25(OH)cholecalciferol ng/ml 27.8 ± 14.9
54.0 ± 11.40
0.000
Table 3. HbA1c % in study groups
Status
Diabetic

Study groups
Severe deficiency
Moderate deficiency
Insufficiency
Sufficiency
Total
Control Subjects
Total

Healthy control

50.00

Mean ± SD
10.1 ± 2.8
9.2 ± 2.3
10.1 ± 2.0
9.8 ± 2.3
9.7 ± 2.3
5.5 ± 0.7
5.5 ± 0.7

46.36

45.00

25(OH)D3 ng/ml

40.00
35.00
28.18

30.00
25.00
20.00
15.00
10.00
5.00
0.00
HbA1c ≥7

HbA1c <7

Figure 1. Comparing 25- (OH) cholecalciferol levels in controlled and uncontrolled diabetic patients.

Amar B., et al..
https://digitalcommons.aaru.edu.jo/zumj/vol27/iss1/36

135 | P a g e
4

Mohamed et al.: Vitamin D Deficiency Among Type 2 Diabetic Patients in Najran Are

January. 2021 Volume 27 Issue 1

10.21608/zumj.2020.26422.1782

60.0

54.0

25(OH)D3 ng/ml

50.0

41.9

40.0
30.0

23.1

20.0

14.6
6.6

10.0
0.0
Sufficiency

Insufficiency

Moderate
deficiency

Sever deficiency

Control

Figure 2. Comparing 25(OH) vitamin D levels various studied groups.

Figure 3. Correlation of 25(OH) vitamin D with HbA1c% in diabetic and healthy control subjects
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Figure 4. Correlation of 25(OH) vitamin D with fasting blood glucose in diabetic and healthy control
subjects.
shown that vitamin D deficiency was detected
in around 70.85% of type 2 diabetic patients
DISCUSSION
Saudi Arabia has been ranked by the World
compared to the level of non-diabetic healthy
Health Organization as having the second
control subjects [15].
highest rate of diabetes in the Middle East with
The study revealed that 8% of all diabetic
an estimated population of 7 million suffering
patient had severe 25(OH) vitamin D3
from diabetes and more than 3 million with predeficiency,
27.6 % were moderately
diabetes [12], on the other hand Vitamin D
deficient, 19.6 % had insufficient value, this
deficiency has been proven to be common in
result is slightly lower than the results of Mauss
Saudi adults especially among females and in
et al who found that 13% of all participants
the younger age groups [13].
were having a severe deficiency whereas 33%
This study explored the relationship between
were moderately deficient [11].
vitamin D deficiency and T2DM. We found a
Results of several previous studies revealed a
significant bivariate association of T2DM with
non-significant and even an inverse correlation
vitamin D deficiency. In diabetic patients, it
between 25(OH) D3 with HbA1c %levels in
was found that 25 (OH) vitamin D3 deficiency
diabetic patients. In a cohort study, in patients
prevalence is around 55.3 %; Serdar Olt found
with T2DM when compared to the control
that 8.4% of the diabetic patients had
group it was found that there was an inverse
relationship between glycosylated hemoglobin
insufficient vitamin D levels [5]. On the other
levels and 25(OH) D3 levels in. These results
hand 89.2% of diabetic patients had insufficient
imply that 25(OH) D3 levels may exert an
vitamin D levels as demonstrated by Bayani et
al [14], in comparison to the Mehta et al study
effect in the control of glucose in diabetes
mellitus type 2 [16 - 17]. Our study has
whereby 68% of diabetic patients had
demonstrated a non-significant negative
insufficient vitamin D levels [8]. As shown by
correlation with the fasting blood sugar.
the study there was a significantly low 25(OH)
Vitamin D3 level in diabetic patients; this
The reported associations between T2DM, and
vitamin D deficiency are highlighted earlier
finding is consistent with results from previous
moreover, the role of vitamin D in the insulin
studies, as Bayani et al. demonstrated that the
pathway is still a matter of debate. Based on
mean vitamin D values were significantly lower
preclinical studies, vitamin D appears to play an
in diabetic patients as compared to the healthy
essential regulatory role in calcium influx into β
control group [14]. In the Antalya study it was
Amar B., et al..
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cells, insulin secretion, and β cell survival.
Vitamin D deficiency impairs glucose-mediated
insulin secretion in rat pancreatic beta cells,
whereas supplementation with vitamin D seems
to restore such glucose-stimulated insulin
secretion [18 - 19].
As stated above, diabetes was found to be
significantly correlated with vitamin D
deficiency, which is congruent with other
studies. Those studies already had described the
mechanisms through which vitamin D can
affect the glucose metabolism. The binding of
the circulating active form, 1,25(OH)2D, to
vitamin D receptor, is expressed in pancreatic β
cells [20], furthermore, a vitamin D response
element was found to be present in the insulin
gene [21], presence of vitamin D receptor in
skeletal muscle [22] and the fact that the
transcription of insulin receptor genes is
increased via 1,25(OH)2D [23], moreover,
there is suppression of the renin gene with
subsequent reduction in the hyperglycemic
induced renin levels increase within the
pancreatic β cells .The renin-angiotensin
activity blockade has been proposed as a novel
target for diabetes treatment [21].
Until further confirmatory causation studies are
available, it is recommended that greater global
attention be devoted to assessment of vitamin D
levels, to reduce the risk for developing T2DM
which, in turn, may affect the vitamin D levels.
This can act as a guide for practitioners in their
treatment and management.
CONCLUSION
In conclusion, the findings of our study suggest
that there is a high incidence of vitamin D
deficiency in diabetic patients in the Najran
area. Vitamin D is inversely correlated with
FBS and HbA1c, finally, the uncontrolled
diabetes is associated with low level of vitamin
D.
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